DE:08HH Stock Latest News
Company AnnouncementsFosun Pharma Issues Unaudited Q3 2026 Report With Governance Assurances5d ago
Pre-EarningsSFOSF Upcoming Earnings Report: What to Expect?1w ago
Company AnnouncementsFosun Pharma Sets October Board Meeting to Approve Q3 Results2w ago
Company AnnouncementsFosun Pharma Wins China Trial Nod for Vitiligo Drug FXS56261M ago
Company AnnouncementsFosun Pharma Launches Up to HK$1 Billion H-Share Buyback Plan1M ago
Company AnnouncementsFosun Pharma Wins China Approval for New Luvometinib Indication1M ago
Company AnnouncementsFosun Pharma Grants New H Share RSUs to 100 Employees Under 2025 Incentive Scheme2M ago
Company AnnouncementsFosun Pharma Unit Secures Exclusive Rights to Advanced Bispecific Antibody Drug2M ago
Company AnnouncementsShanghai Fosun Pharma Executes HK$3.6 Million H-Share Buyback2M ago
Company AnnouncementsFosun Pharma Posts Modest Profit Growth in First-Half 2026 Results2M ago
Company AnnouncementsFosun Pharma Subsidiary Advances COPD Drug FXS7553 Into Phase II Trial in China2M ago
Company AnnouncementsFosun Pharma Subsidiary Wins China Approval for Heart Failure Injection2M ago
Company AnnouncementsFosun Pharma Subsidiary Wins Approval for Pediatric Constipation Drug in China3M ago- Company AnnouncementsFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination Drug3M ago
- Company AnnouncementsFosun Pharma Unit Wins NMPA Nod for Parkinson’s Drug Trial3M ago
Company AnnouncementsFosun Pharma Wins NMPA Nod for FXR0906 Hypertriglyceridemia Trial3M agoCompany AnnouncementsFosun Pharma Subsidiary Wins Approval for New Traditional Chinese Medicine Granules4M ago
Company AnnouncementsFosun Pharma Moves Ahead With Spin-Off Listing of Fosun Adgenvax in Hong Kong4M ago